Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings

WJ Panenka, RM Procyshyn, T Lecomte… - Drug and alcohol …, 2013 - Elsevier
Methamphetamine (MA) is a highly addictive psychostimulant drug that principally affects the
monoamine neurotransmitter systems of the brain and results in feelings of alertness …

[HTML][HTML] Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: potential therapeutic impacts

AP Daiwile, S Jayanthi, JL Cadet - Neuroscience & Biobehavioral Reviews, 2022 - Elsevier
Methamphetamine (METH) use, and misuse are associated with severe socioeconomic
consequences. METH users develop tolerance, lose control over drug taking behaviors, and …

Methamphetamine psychosis: epidemiology and management

S Glasner-Edwards, LJ Mooney - CNS drugs, 2014 - Springer
Psychotic symptoms and syndromes are frequently experienced among individuals who use
methamphetamine, with recent estimates of up to approximately 40% of users affected …

Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized …

PO Coffin, GM Santos, J Hern, E Vittinghoff… - JAMA …, 2020 - jamanetwork.com
Importance Methamphetamine use is increasingly prevalent and associated with HIV
transmission. A previous phase 2a study of mirtazapine demonstrated reductions in …

Mental health outcomes associated with the use of amphetamines: A systematic review and meta-analysis

R McKetin, J Leung, E Stockings, Y Huo, J Foulds… - …, 2019 - thelancet.com
Background The use of amphetamines is a global public health concern. We summarise
global data on use of amphetamines and mental health outcomes. Methods A systematic …

Prevalence and correlates of substance use among trans* female youth ages 16–24 years in the San Francisco Bay Area

C Rowe, GM Santos, W McFarland… - Drug and alcohol …, 2015 - Elsevier
Background Substance use is highly prevalent among transgender (trans*) females and has
been associated with negative health outcomes, including HIV infection. Little is known …

Methamphetamine induces systemic inflammation and anxiety: the role of the gut–immune–brain axis

M Davidson, M Mayer, A Habib, N Rashidi… - International journal of …, 2022 - mdpi.com
Methamphetamine (METH) is a highly addictive drug abused by millions of users worldwide,
thus becoming a global health concern with limited management options. The inefficiency of …

The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a US national sample

N Krawczyk, KA Feder, B Saloner, RM Crum… - Drug and alcohol …, 2017 - Elsevier
Background Psychiatric disorders are highly comorbid with substance use disorders and
play an important role in their course and recovery. However, the impact of comorbidity on …

Dark times: the role of negative reinforcement in methamphetamine addiction

AC May, RL Aupperle, JL Stewart - Frontiers in psychiatry, 2020 - frontiersin.org
Methamphetamine use is associated with substantial adverse outcomes including poor
mental and physical health, financial difficulties, and societal costs. Despite deleterious long …

Psychiatric comorbidity in methamphetamine dependence

R Salo, K Flower, A Kielstein, MH Leamon… - Psychiatry …, 2011 - Elsevier
The primary aim of the present study was to assess the prevalence of psychiatric comorbidity
in a large sample of methamphetamine (MA)-dependent subjects using a validated …